Aktiesnakken — Juni 2013
-
jeg siger slet ikke at det her er den næste genmab. Jeg kan bare rigtigt godt lide salgstal i biotek. det gør altså en del for gennemsigtigheden i casen
-
De har jo sanofi i ryggen. Det betyder noget
-
man kan ikke sammenligne novo og zeal. men man kan sammenligne novo og sanofi
-
nej hvad sagde han?
-
det er krig. ofcourse. men lantus har brug for dem som patentforlænger. Der er rigtigt mange penge i det
-
alle jeres spørgsmål her tak http://www.proinvestor.com/boards/65789/
-
-
maras
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind